Adage Capital Partners Gp, L.L.C. Regenxbio Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $2.01 Million - $4.06 Million	165,073 New	165,073 $3.48 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $19.5 Million - $24.6 Million	-300,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $8.16 Million - $22.3 Million	-300,000 Reduced 50.0%	300,000 $21.5 Million
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $4.21 Million - $6.56 Million	175,000 Added 41.18%	600,000 $17.9 Million
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $1.3 Million - $1.73 Million	-50,000 Reduced 10.53%	425,000 $14.1 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $8.55 Million - $15.7 Million	475,000	475,000 $15.7 Million

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.